News

The Impact-DCM trial is evaluating the use of cardiac repair cells (CRCs), a mixture of stem and progenitor cells derived from a patient’s own bone marrow, for the

Serica Technologies, a medical device company, has received 510(k) clearance from the FDA for its SeriScaffold silk-based, long term bioresorbable scaffold technology. According to the company, the SeriScaffold

According to Microsoft, GSK will deploy its Business Productivity Online Suite, including Exchange Online, SharePoint Online, Office Communications Online, Office Live Meeting and the Deskless Worker Suite. Bill

The certificate of compliance has a five-year term and was issued by the State Food and Drug Administration following a site inspection. The good manufacturing practice (GMP) certification

The agreement is intended to increase the availability of the NESS L300 among all OPGA O&P members and to improve the care for persons with foot drop, suffering

Additionally, Hi-Tech may pay up to $4 million in performance incentives tied to future ECR product sales and profits. Under the terms of the acquisition Hi-Tech receives rights

The company also signed a licensing agreement on the same product for all countries except Japan with Teikoku Seiyaku’s US subsidiary, Teikoku Pharma USA. Under the terms of

Penwest Pharmaceuticals, a drug development company, has started dosing in a Phase Ib clinical trial of A0001, a compound the company is developing for the treatment of mitochondrial

According to ProGenTech, the system will incorporate Innovative Biosensor’s proprietary Cellular Analysis and Notification of Antigen Risks and Yields technology, a cell-based approach for detecting various pathogens, into